1. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
2. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
3. |
Lower asthma-related costs with fluticasone propionate |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
4. |
Rituximab regimen shows potential in rheumatoid arthritis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
5. |
Rosuvastatin provides superior benefits in lipid therapy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 6-7
Larry Prescott,
Preview
|
|
摘要:
AstraZeneca's rosuvastatin ['Crestor'] significantly reduces levels of LDL-cholesterol in patients with hypercholesterolaemia, according to new data presented recently at the 50th Annual Scientific Session of the American College of Cardiology [Orlando, US; March 2001]. Rosuvastatin reduced LDL-cholesterol levels by 40-58%; this improvement was significant, compared with other HMG CoA reductase inhibitors [statins], atorvastatin, simvastatin and pravastatin. Furthermore, rosuvastatin increased levels of HDL-cholesterol by up to 13%, and up to 87% of rosuvastatin recipients met recommended target cholesterol levels.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
6. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
7. |
Tezosentan shows potential for treating heart failure |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 9-10
Larry Prescott,
Preview
|
|
摘要:
Tezosentan, the first of a new class of drugs called endothelin receptor antagonists, may help stabilise patients with acute decompensated heart failure without the adverse effects associated with traditional therapies. Detailed results from the Randomized Intravenous TeZosentan (RITZ)-2 study demonstrating the haemodynamic benefits of this novel drug were presented at the 50th Annual Scientific Session of the American College of Cardiology [Orlando, US; March 2001].
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
8. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
9. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
10. |
Gemfibrozil beneficial in men with low HDL-cholesterol |
|
Inpharma Weekly,
Volume &NA;,
Issue 1282,
2001,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|